These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 30075293

  • 1. A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-α and IL-6 in an iPSC-based blood-brain barrier model.
    Mantle JL, Lee KH.
    Neurobiol Dis; 2018 Nov; 119():113-120. PubMed ID: 30075293
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro.
    Dohgu S, Takata F, Matsumoto J, Kimura I, Yamauchi A, Kataoka Y.
    Microvasc Res; 2019 Jul; 124():61-66. PubMed ID: 30885616
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D.
    Jamieson JJ, Linville RM, Ding YY, Gerecht S, Searson PC.
    Fluids Barriers CNS; 2019 Jun 06; 16(1):15. PubMed ID: 31167667
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
    Hollmann EK, Bailey AK, Potharazu AV, Neely MD, Bowman AB, Lippmann ES.
    Fluids Barriers CNS; 2017 Apr 13; 14(1):9. PubMed ID: 28407791
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro model of cerebral ischemia by using brain microvascular endothelial cells derived from human induced pluripotent stem cells.
    Kokubu Y, Yamaguchi T, Kawabata K.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):577-583. PubMed ID: 28336435
    [Abstract] [Full Text] [Related]

  • 12. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
    Versele R, Sevin E, Gosselet F, Fenart L, Candela P.
    Int J Mol Sci; 2022 Sep 06; 23(18):. PubMed ID: 36142143
    [Abstract] [Full Text] [Related]

  • 13. Neuroinflammatory astrocytes generated from cord blood-derived human induced pluripotent stem cells.
    Zhou Q, Viollet C, Efthymiou A, Khayrullina G, Moritz KE, Wilkerson MD, Sukumar G, Dalgard CL, Doughty ML.
    J Neuroinflammation; 2019 Aug 09; 16(1):164. PubMed ID: 31395092
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model.
    Clark PA, Al-Ahmad AJ, Qian T, Zhang RR, Wilson HK, Weichert JP, Palecek SP, Kuo JS, Shusta EV.
    Mol Pharm; 2016 Sep 06; 13(9):3341-9. PubMed ID: 27421304
    [Abstract] [Full Text] [Related]

  • 18. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y, Sun X, Liu H, Huang L, Meng G, Ding Y, Su W, Lu J, Gong S, Terstappen GC, Zhang R, Zhang W.
    Neurosci Bull; 2019 Dec 06; 35(6):996-1010. PubMed ID: 31079318
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.